+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Disposable Syringes Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 186 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336330
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The disposable syringes market stands at the forefront of healthcare transformation, driving standards in infection control, procurement, and device safety while adapting to regulatory and technology shifts.

Market Snapshot: Disposable Syringes Market Growth and Outlook

The disposable syringes market expanded from USD 17.04 billion in 2024 to USD 18.13 billion in 2025. Backed by an expected CAGR of 6.83%, the sector is forecasted to surpass USD 28.91 billion by 2032. Growth is fueled by diversification beyond standard injections to include complex therapeutic and diagnostic functions. Escalating global demand for single-use safety devices is prompting active adaptation among industry participants, who are responding to evolving technology, regulatory oversight, and sustainability imperatives. These trends influence procurement strategies and end-user adoption worldwide.

Scope & Segmentation: Mapping the Disposable Syringes Market

This report provides a comprehensive analysis of the disposable syringes market, covering strategic segments and their relevance for decision-makers:

  • Type: Encompasses conventional syringes (2-part, 3-part, hypodermic, insulin, Luer lock, precision) and safety syringes with non-retractable and retractable safety features.
  • Needle Type: Covers blunt tip, fixed needle, hypodermic, micro-needle, and removable needle configurations, enabling varied clinical applications and performance requirements.
  • Capacity: Includes sizes ranging from less than 1 mL, through 1 mL–20 mL, to greater than 20 mL, supporting broad dosing and therapeutic scenarios.
  • Material: Features plastic syringes (polycarbonate, polyethylene, polypropylene), biodegradable or compostable alternatives, and glass syringes, aligning with safety, cost, and sustainability considerations.
  • Application: Covers medical uses including drug delivery, insulin administration, diagnostics, vaccinations for all age groups, and aesthetic procedures, supporting diverse healthcare and wellness demands.
  • End User: Targets ambulatory surgical centers, diagnostic labs, home healthcare, hospitals and clinics, military and field medical units, plus veterinary care providers.
  • Regions: Markets span the Americas (with country-level detail for North and Latin America), Europe, Middle East & Africa, and Asia-Pacific, each reflecting differing regulatory settings and market maturity.
  • Leading Companies: Spotlights innovators and major players such as AdvaCare Pharma, B. Braun SE, Baxter International, Becton Dickinson, Cole-Parmer, Fresenius Kabi, GPE Group, Henke Sass Wolf, Hindustan Syringes, Hu-Friedy, ICU Medical, ISCON SURGICALS, Jiangsu Shenli Medical, KD Medical, Nipro, Novo Nordisk, Retractable Technologies, Shree Umiya Surgical, Taizhou Sanxin, Terumo, Thermo Fisher Scientific, UltiMed, Vita Needle Company, Weigao Medical, and Yangzhou Medline.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Advances in digital traceability systems and automated assembly processes are driving improvements in both manufacturing efficiency and quality control, supporting enhanced assurance for healthcare providers.
  • A rise in regulatory scrutiny is boosting the adoption of passive safety devices, reducing occupational risks for clinicians and reinforcing compliance in high-volume clinical settings.
  • Adoption of sustainable materials—such as bio-based and compostable polymers—supports alignment with environmental regulations and reduces the environmental burden of disposables in medical waste streams.
  • Manufacturers are leveraging strategic alliances with contract manufacturing partners to accelerate product innovation, enabling faster time-to-market for next-generation syringe systems in established and emerging markets alike.
  • Growing demand for connected medical devices and prefilled options fosters integration with digital health tools, supporting medication adherence and real-time usage monitoring in diverse care environments.

Tariff Impact: Navigating Supply Chain and Sourcing Pressures

Recently enacted United States tariff measures have affected disposable syringe manufacturing costs, particularly through higher levies on key polymer and steel inputs. In response, producers are diversifying their supply chains and exploring nearshoring options, prompting changes in pricing strategies for major healthcare procurement groups. Hospitals and immunization programs are adapting to this evolving context by enhancing contractual flexibility and risk management processes to mitigate potential supply disruptions stemming from ongoing trade policy shifts.

Methodology & Data Sources: Ensuring Analytical Rigor

This analysis is built upon a mixed-method approach, including primary interviews with procurement leaders, clinicians, and compliance specialists. Industry publications, company filings, and regulatory documents supplement this insight. Quantitative market segmentation is rigorously validated via trade data and multi-expert panel reviews, promoting data integrity and reliability.

The Disposable Syringes Market: Why This Report Matters

  • Empowers decision-makers to identify attractive market segments and prepare for the impact of shifting regulations, evolving technologies, and increasing environmental standards.
  • Delivers insights that inform procurement, sourcing, and investment strategies, supporting risk mitigation and long-term planning in a dynamic healthcare landscape.
  • Details geographic and supplier dynamics, highlighting innovation and policy trends crucial for competitiveness and operational resilience.

Conclusion

This report gives senior leaders the context needed to address regulatory, technology, and sustainability priorities in the disposable syringes market. Clear, actionable insights support strategic decision-making across procurement and operations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Advancements in digital tracking features for prefilled syringes enhancing medication monitoring
5.2. Growing adoption of safety engineered auto-disable syringes in immunization programs
5.3. Rising popularity of prefilled injectable formulations in specialty biotech therapies fueling delivery efficiency
5.4. Integration of biodegradable polymers to address environmental concerns in syringe disposal
5.5. Collaborations among pharmaceutical companies and device manufacturers accelerating custom syringe designs
5.6. Growing demand for prefilled syringe delivery systems in biotech and specialty drug therapies
5.7. Expanding use of auto-disable safety syringes in global vaccination drives reducing needle reuse
5.8. Development of eco-friendly syringe production using plant-based biodegradable materials for waste management
5.9. Integration of smart RFID and barcode tracking in prefilled syringes improving patient compliance
5.10. Auto-disable safety syringes scaling up in large-scale vaccination campaigns
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Disposable Syringes Market, by Type
8.1. Conventional Syringes
8.1.1. 2-Part Syringes
8.1.2. 3-Part Syringes
8.1.3. Hypodermic Syringes
8.1.4. Insulin Syringes
8.1.5. Luer Lock Syringes
8.1.6. Precision Syringes
8.2. Safety Syringes
8.2.1. Non-Retractable Safety Syringes
8.2.2. Retractable Safety Syringes
9. Disposable Syringes Market, by Needle Type
9.1. Blunt Tip Needle
9.2. Fixed Needle
9.3. Hypodermic Needle
9.4. Micro-needle
9.5. Removable Needle
10. Disposable Syringes Market, by Capacity
10.1. 1 mL-20 mL
10.2. < 1 mL
10.3. >20 mL
11. Disposable Syringes Market, by Material
11.1. Biodegradable/Compostable Materials
11.2. Glass Syringes
11.3. Plastic Syringes
11.3.1. Polycarbonate
11.3.2. Polyethylene
11.3.3. Polypropylene
12. Disposable Syringes Market, by Application
12.1. Cosmetics
12.2. Diagnostic
12.3. Therapeutic
12.3.1. Drug Delivery
12.3.2. Insulin Delivery
12.4. Vaccination
12.4.1. Adult Vaccination
12.4.2. Childhood Vaccination
13. Disposable Syringes Market, by End User
13.1. Ambulatory Surgical Centers
13.2. Diagnostic Laboratories
13.3. Home Healthcare
13.4. Hospitals & Clinics
13.5. Military & Field Medical Units
13.6. Veterinary Clinics
14. Disposable Syringes Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Disposable Syringes Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Disposable Syringes Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AdvaCare Pharma
17.3.2. B. Braun SE
17.3.3. Baxter International, Inc.
17.3.4. Becton, Dickinson and Company
17.3.5. Cole-Parmer Instrument Company, LLC
17.3.6. Fresenius Kabi AG
17.3.7. GPE Group
17.3.8. Henke Sass Wolf GmbH
17.3.9. Hindustan Syringes & Medical Devices Ltd.
17.3.10. Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
17.3.11. ICU Medical, Inc.
17.3.12. ISCON SURGICALS LTD.
17.3.13. Jiangsu Shenli Medical Production Co., Ltd.
17.3.14. KD Medical GmbH Hospital Products
17.3.15. Nipro Corporation
17.3.16. Novo Nordisk A/S
17.3.17. Retractable Technologies, Inc.
17.3.18. Shree Umiya Surgical Pvt. Ltd.
17.3.19. Taizhou Sanxin Medical Technology Co., Ltd.
17.3.20. Terumo Corporation
17.3.21. Thermo Fisher Scientific Inc.
17.3.22. UltiMed, Inc.
17.3.23. Vita Needle Company
17.3.24. Weigao Meidcal international Co., Ltd
17.3.25. Yangzhou Medline Industry Co., Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Disposable Syringes market report include:
  • AdvaCare Pharma
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cole-Parmer Instrument Company, LLC
  • Fresenius Kabi AG
  • GPE Group
  • Henke Sass Wolf GmbH
  • Hindustan Syringes & Medical Devices Ltd.
  • Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
  • ICU Medical, Inc.
  • ISCON SURGICALS LTD.
  • Jiangsu Shenli Medical Production Co., Ltd.
  • KD Medical GmbH Hospital Products
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Shree Umiya Surgical Pvt. Ltd.
  • Taizhou Sanxin Medical Technology Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • UltiMed, Inc.
  • Vita Needle Company
  • Weigao Meidcal international Co., Ltd
  • Yangzhou Medline Industry Co., Ltd.

Table Information